Kuderedza kuungana kweropa (anticoagulant) inzira yekuderedza kuumbwa kwefibrin thrombus kuburikidza nekushandisa mishonga inodzivisa kuungana kweropa (anticoagulant drugs) kuderedza maitiro enzira yemukati uye nzira yemukati yekuungana kweropa (intrinsic coagulation pathway).
Mushonga wekudzivirira maplatelet ndewekutora mishonga yekudzivirira maplatelet kuderedza kunamira uye kuungana kwemaplatelet, nokudaro zvichideredza maitiro ekuumbwa kweplatelet thrombus. Mukurapa, mishonga yekudzivirira kuungana kweropa inowanzo shandiswa inosanganisira warfarin neheparin, izvo zvinoderedza mukana wekuumbwa kwefibrinogen thrombus kuburikidza nenzira dzakasiyana dzekudzivirira kuungana kweropa. Semuenzaniso, warfarin inowanzo shandiswa mukurapa kwekudzivirira kuungana kweropa mushure mekuvhiyiwa kwevharuvhu yemoyo, uye heparin inowanzo shandiswa mukurapa venous thrombosis yemakumbo epasi.
Mishonga inowanzo shandiswa yekudzivirira maplatelet inosanganisira aspirin, Plavix, nezvimwewo. Mishonga iyi inogona kudzivirira kuungana kwemaplatelet kuburikidza nekubatana kwakasiyana, nokudaro ichidzivirira kuumbwa kweplatelet thrombus. Mukurapa, inoshandiswa kudzivirira chirwere chemwoyo, cerebral thrombosis nezvimwe zvirwere.
Beijing SUCCEEDER seimwe yemhando dzinotungamira muChina Diagnostic Market yeThrombosis neHemostasis, SUCCEEDER yakasangana nezvikwata zveR&D, Production, Marketing Sales and Service, zvinopa coagulation analyzers uye reagents, blood rheology analyzers, ESR neHCT analyzers, platelet aggregation analyzers dzine ISO13485，CE Certification uye FDA yakanyorwa.
Kadhi rebhizinesi
WeChat yeChinese